One year back while I was traveling with my boss for a small conference in Delhi. Aditya my boss started telling me about reverse merger of Merck by Schering-Plough, I was surprised to know that as I had a always known that Merck had acquired Schering-plough.....leaving that story apart, in the current scenario if I look into world’s largest pharma Pfizer's current pipeline, it is somewhat dry with its major block buster getting off patented last month, there are not many revolutionary drugs in its somewhat dry pipeline which will give it a huge ROI in next 10 years and it also do not have a strong biopharma presence .....on the other hand the company which is making mark and has been into lot action in biological for a while is Sanofi Aventis of france.........with Sanofi's strong biological pipeline and Pfizer's strength in world class chemical synthesis...in future can we think of a reverse merger of Pfizer by Sanofi ???
